Wals-Siezenheim, Austria

Sébastien Couillard-Despres


 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Regensburg, DE (2014)
  • Salzburg, AT (2016)
  • Wals-Siezenheim, AT (2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sébastien Couillard-Despres: Innovator in Neurological Interventions

Introduction

Sébastien Couillard-Despres is a notable inventor based in Wals-Siezenheim, Austria. He has made significant contributions to the field of medical interventions, particularly in the treatment of neurological disorders. With a total of 4 patents to his name, his work is recognized for its potential impact on healthcare.

Latest Patents

One of his latest patents focuses on chromane-like cyclic prenylflavonoids for medical intervention in neurological disorders. This invention relates to specific compounds that are designed for the treatment or prevention of neurological disorders. The compounds are also intended to promote neuronal differentiation, neurite outgrowth, and neuroprotection. This innovative approach highlights the potential of these compounds in advancing neurological health.

Career Highlights

Throughout his career, Sébastien has worked with prominent companies, including F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in the field of medical research and innovation.

Collaborations

Sébastien has collaborated with notable individuals such as Ludwig Aigner and Francisco Javier Rivera. These partnerships have likely enriched his research and development efforts.

Conclusion

Sébastien Couillard-Despres stands out as an inventor dedicated to advancing medical science, particularly in the realm of neurological health. His innovative patents and collaborations reflect his commitment to improving treatment options for neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…